BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 24222353)

  • 1. Detection of Alternatively Spliced or Processed RNAs in Cancer Using Oligonucleotide Microarray.
    Gencheva M; Yang L; Lin GB; Lin RJ
    Cancer Treat Res; 2013; 158():25-40. PubMed ID: 24222353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unconstrained mining of transcript data reveals increased alternative splicing complexity in the human transcriptome.
    Mollet IG; Ben-Dov C; Felício-Silva D; Grosso AR; Eleutério P; Alves R; Staller R; Silva TS; Carmo-Fonseca M
    Nucleic Acids Res; 2010 Aug; 38(14):4740-54. PubMed ID: 20385588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic analysis of RNA alternative splicing in cancers.
    Xing Y
    Front Biosci; 2007 May; 12():4034-41. PubMed ID: 17485356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA sequencing and transcriptome arrays analyses show opposing results for alternative splicing in patient derived samples.
    Nazarov PV; Muller A; Kaoma T; Nicot N; Maximo C; Birembaut P; Tran NL; Dittmar G; Vallar L
    BMC Genomics; 2017 Jun; 18(1):443. PubMed ID: 28587590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and measurement of alternative splicing using splicing-sensitive microarrays.
    Srinivasan K; Shiue L; Hayes JD; Centers R; Fitzwater S; Loewen R; Edmondson LR; Bryant J; Smith M; Rommelfanger C; Welch V; Clark TA; Sugnet CW; Howe KJ; Mandel-Gutfreund Y; Ares M
    Methods; 2005 Dec; 37(4):345-59. PubMed ID: 16314264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing.
    Shkreta L; Bell B; Revil T; Venables JP; Prinos P; Elela SA; Chabot B
    Cancer Treat Res; 2013; 158():41-94. PubMed ID: 24222354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A microarray configuration to quantify expression levels and relative abundance of splice variants.
    Fehlbaum P; Guihal C; Bracco L; Cochet O
    Nucleic Acids Res; 2005 Mar; 33(5):e47. PubMed ID: 15760843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of isoform expression from splicing array using multiple comparisons.
    Nair TM
    Methods Mol Biol; 2012; 802():113-21. PubMed ID: 22130877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
    Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
    Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studying Isoform-Specific mRNA Recruitment to Polyribosomes with Frac-seq.
    Martinez-Nunez RT; Sanford JR
    Methods Mol Biol; 2016; 1358():99-108. PubMed ID: 26463379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative Splicing in Next Generation Sequencing Data of Saccharomyces cerevisiae.
    Schreiber K; Csaba G; Haslbeck M; Zimmer R
    PLoS One; 2015; 10(10):e0140487. PubMed ID: 26469855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting splice variant from DNA chip expression data.
    Hu GK; Madore SJ; Moldover B; Jatkoe T; Balaban D; Thomas J; Wang Y
    Genome Res; 2001 Jul; 11(7):1237-45. PubMed ID: 11435406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of tissue-specific exons using comprehensive human exon microarrays.
    Clark TA; Schweitzer AC; Chen TX; Staples MK; Lu G; Wang H; Williams A; Blume JE
    Genome Biol; 2007; 8(4):R64. PubMed ID: 17456239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms regulating the tumor-targeting potential of splice-activated gene expression.
    Hayes GM; Dougherty ST; Davis PD; Dougherty GJ
    Cancer Gene Ther; 2004 Dec; 11(12):797-807. PubMed ID: 15359288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RASE: recognition of alternatively spliced exons in C.elegans.
    Rätsch G; Sonnenburg S; Schölkopf B
    Bioinformatics; 2005 Jun; 21 Suppl 1():i369-77. PubMed ID: 15961480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pre-mRNA alternative splicing in cancer: functional impact, molecular mechanisms and therapeutic perspectives].
    Revil T; Shkreta L; Chabot B
    Bull Cancer; 2006 Sep; 93(9):909-19. PubMed ID: 16980234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-depth characterization of breast cancer tumor-promoting cell transcriptome by RNA sequencing and microarrays.
    Callari M; Guffanti A; Soldà G; Merlino G; Fina E; Brini E; Moles A; Cappelletti V; Daidone MG
    Oncotarget; 2016 Jan; 7(1):976-94. PubMed ID: 26556871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin's lymphoma cells express alternatively spliced forms of HDM2 with multiple effects on cell cycle control.
    Sánchez-Aguilera A; García JF; Sánchez-Beato M; Piris MA
    Oncogene; 2006 Apr; 25(18):2565-74. PubMed ID: 16331255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep RNA sequencing reveals a high frequency of alternative splicing events in the fungus Trichoderma longibrachiatum.
    Xie BB; Li D; Shi WL; Qin QL; Wang XW; Rong JC; Sun CY; Huang F; Zhang XY; Dong XW; Chen XL; Zhou BC; Zhang YZ; Song XY
    BMC Genomics; 2015 Feb; 16(1):54. PubMed ID: 25652134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel protein isoform derived from cancer-related splicing variants using combined analysis of transcriptome and proteome.
    Hatakeyama K; Ohshima K; Fukuda Y; Ogura S; Terashima M; Yamaguchi K; Mochizuki T
    Proteomics; 2011 Jun; 11(11):2275-82. PubMed ID: 21548097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.